CGM Academy for Youth With Type 1 Diabetes
Conditions: Type1 Diabetes Interventions: Behavioral: CGM Academy Sponsors: Children ' s Hospital Los Angeles Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2024 Category: Research Source Type: clinical trials
A Study of the Higher Cognitive Functions of the Human Brain With Single-neuron Activity Recording
Conditions: Cognition Sponsors: Huashan Hospital; Chinese Academy of Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2024 Category: Research Source Type: clinical trials
Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancer
Conditions: Liver Cancer Interventions: Drug: chidamide combined with Sintilimab and bevacizumab Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2024 Category: Research Source Type: clinical trials
Clinical Trial of BT02 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumor Interventions: Drug: BT02 monoclonal antibody injection Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
Irinotecan, TAS-102 Plus Bevacizumab as a Third-Line or Beyond Therapy in mCRC Patients
Conditions: Metastatic Colorectal Cancer Interventions: Drug: Irinotecan, Trifluridine/tipiracil (TAS-102) plus Bevacizumab Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain Metastases
Conditions: Brain Metastases Interventions: Radiation: magnetic resonance imaging-guided adaptive radiotherapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine as Conversion Therapy of Locally Advanced Colorectal Cancer
Conditions: Colorectal Cancer Interventions: Drug: Nanoliposomal Irinotecan, Oxaliplatin plus Capecitabine Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
A Multicentre Prospective Cohort Study: Intensive Adjuvant Therapy for TNBC With BRCA Gene Mutation
Conditions: Early-stage Triple-negative Breast Cancer With BRCA1/2 Mutations Interventions: Other: no intervention Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC
Conditions: Nanoliposomal Irinotecan; Cadonilimab; Oxaliplatin; Capecitabine; First-Line; Advanced Cancer; Pancreatic Adenocarcinoma; Drug Use Interventions: Drug: Nanoliposomal Irinotecan+Oxaliplatin +Capecitabine+Cadonilimab Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
A Multicentre Prospective Cohort Study: Effect of (Neo)Adjuvant Therapy on Lipids in Young Breast Cancer Patients
Conditions: Young Breast Cancer Patient; Lipids; Anti-tumour Drug Therapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2024 Category: Research Source Type: clinical trials
Mechanism and Application of DBS in the Treatment of PD
Conditions: Parkinson ' s Disease and Parkinsonism Interventions: Device: microelectrode stimulation of DBS Sponsors: Beijing Tiantan Hospital; Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China; Tsinghua University; Boston Children ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2024 Category: Research Source Type: clinical trials
Rivastigmine to Prevent Recurrence of Antimuscarinic Delirium
Conditions: Anticholinergic Toxicity Interventions: Drug: Rivastigmine; Drug: Placebo Sponsors: Washington University School of Medicine; American Academy of Clinical Toxicology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2024 Category: Research Source Type: clinical trials
Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients
Conditions: Peritoneal Dialysis Complication; Renal Function Aggravated; Sodium-glucose Co-transporter-2 Inhibitors Interventions: Drug: Dapagliflozin Sponsors: Sichuan Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2024 Category: Research Source Type: clinical trials
Mast Cells and Its Proteases in COPD
Conditions: COPD Exacerbation Interventions: Other: Biopsy Sponsors: Voronezh N.N. Burdenko State Medical Academy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
The Effect of Weekly Semaglutide Treatment on Energy Expenditure
Conditions: Obesity; Drug Interventions: Drug: Semaglutide; Drug: Placebo Sponsors: Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
